{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:24:49Z","timestamp":1773829489014,"version":"3.50.1"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100002301","name":"Estonian Research Council","doi-asserted-by":"crossref","award":["IUT34-12"],"award-info":[{"award-number":["IUT34-12"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002301","name":"Estonian Research Council","doi-asserted-by":"crossref","award":["PRG1021"],"award-info":[{"award-number":["PRG1021"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"United States of America","award":["R01HD078641"],"award-info":[{"award-number":["R01HD078641"]}]},{"name":"United States of America","award":["P50HD096723"],"award-info":[{"award-number":["P50HD096723"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council of Australia","doi-asserted-by":"publisher","award":["APP1120356"],"award-info":[{"award-number":["APP1120356"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003545","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-007274"],"award-info":[{"award-number":["POCI-01-0145-FEDER-007274"]}],"id":[{"id":"10.13039\/501100003545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003545","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o","doi-asserted-by":"publisher","award":["IF\/01262\/2014"],"award-info":[{"award-number":["IF\/01262\/2014"]}],"id":[{"id":"10.13039\/501100003545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centre for Toxicogenomics and Human Health\u2014ToxOmics","award":["UID\/BIM\/00009\/2016"],"award-info":[{"award-number":["UID\/BIM\/00009\/2016"]}]},{"name":"Centre for Toxicogenomics and Human Health\u2014ToxOmics","award":["UIDB\/00009\/2020"],"award-info":[{"award-number":["UIDB\/00009\/2020"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>What is the load, distribution and added clinical value of secondary findings (SFs) identified in exome sequencing (ES) of patients with non-obstructive azoospermia (NOA)?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>One in 28 NOA cases carried an identifiable, medically actionable SF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>In addition to molecular diagnostics, ES allows assessment of clinically actionable disease-related gene variants that are not connected to the patient\u2019s primary diagnosis, but the knowledge of which may allow the prevention, delay or amelioration of late-onset monogenic conditions. Data on SFs in specific clinical patient groups, including reproductive failure, are currently limited.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>The study group was a retrospective cohort of patients with NOA recruited in 10 clinics across six countries and formed in the framework of the international GEMINI (The GEnetics of Male INfertility Initiative) study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>ES data of 836 patients with NOA were exploited to analyze SFs in 85 genes recommended by the American College of Medical Genetics and Genomics (ACMG), Geisinger\u2019s MyCode, and Clinical Genome Resource. The identified 6374 exonic variants were annotated with ANNOVAR and filtered for allele frequency, retaining 1381 rare or novel missense and loss-of-function variants. After automatic assessment of pathogenicity with ClinVar and InterVar, 87 variants were manually curated. The final list of confident disease-causing SFs was communicated to the corresponding GEMINI centers. When patient consent had been given, available family health history and non-andrological medical data were retrospectively assessed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>We found a 3.6% total frequency of SFs, 3.3% from the 59 ACMG SF v2.0 genes. One in 70 patients carried SFs in genes linked to familial cancer syndromes, whereas 1 in 60 cases was predisposed to congenital heart disease or other cardiovascular conditions. Retrospective assessment confirmed clinico-molecular diagnoses in several cases. Notably, 37% (11\/30) of patients with SFs carried variants in genes linked to male infertility in mice, suggesting that some SFs may have a co-contributing role in spermatogenic impairment. Further studies are needed to determine whether these observations represent chance findings or the profile of SFs in NOA patients is indeed different from the general population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>One limitation of our cohort was the low proportion of non-Caucasian ethnicities (9%). Additionally, as comprehensive clinical data were not available retrospectively for all men with SFs, we were not able to confirm a clinico-molecular diagnosis and assess the penetrance of the specific variants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>For the first time, this study analyzed medically actionable SFs in men with spermatogenic failure. With the evolving process to incorporate ES into routine andrology practice for molecular diagnostic purposes, additional assessment of SFs can inform about future significant health concerns for infertility patients. Timely detection of SFs and respective genetic counseling will broaden options for disease prevention and early treatment, as well as inform choices and opportunities regarding family planning. A notable fraction of SFs was detected in genes implicated in maintaining genome integrity, essential in both mitosis and meiosis. Thus, potential genetic pleiotropy may exist between certain adult-onset monogenic diseases and NOA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>This work was supported by the Estonian Research Council grants IUT34-12 and PRG1021 (M.L. and M.P.); National Institutes of Health of the United States of America grant R01HD078641 (D.F.C., K.I.A. and P.N.S.); National Institutes of Health of the United States of America grant P50HD096723 (D.F.C. and P.N.S.); National Health and Medical Research Council of Australia grant APP1120356 (M.K.O\u2019B., D.F.C. and K.I.A.); Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT)\/Minist\u00e9rio da Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o grant POCI-01-0145-FEDER-007274 (A.M.L., F.C. and J.G.) and FCT: IF\/01262\/2014 (A.M.L.). J.G. was partially funded by FCT\/Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior (MCTES), through the Centre for Toxicogenomics and Human Health\u2014ToxOmics (grants UID\/BIM\/00009\/2016 and UIDB\/00009\/2020). M.L.E. is a consultant for, and holds stock in, Roman, Sandstone, Dadi, Hannah, Underdog and has received funding from NIH\/NICHD. Co-authors L.K., K.L., L.N., K.I.A., P.N.S., J.G., F.C., D.M.-M., K.A., K.A.J., M.K.O\u2019B., A.M.L., D.F.C., M.P. and M.L. declare no conflict of interest.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deac100","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T19:16:56Z","timestamp":1650568616000},"page":"1652-1663","source":"Crossref","is-referenced-by-count":20,"title":["Actionable secondary findings following exome sequencing of 836 non-obstructive azoospermia cases and their value in patient management"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4182-2396","authenticated-orcid":false,"given":"Laura","family":"Kasak","sequence":"first","affiliation":[{"name":"Department of Biomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu , Tartu, Estonia"}]},{"given":"Kristiina","family":"Lillepea","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu , Tartu, Estonia"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1948-2495","authenticated-orcid":false,"given":"Liina","family":"Nagirnaja","sequence":"additional","affiliation":[{"name":"Division of Genetics, Oregon National Primate Research Center, Oregon Health & Science University , Beaverton, OR, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6459-2103","authenticated-orcid":false,"given":"Kenneth I","family":"Aston","sequence":"additional","affiliation":[{"name":"Andrology and IVF Laboratory, Department of Surgery (Urology), University of Utah School of Medicine , Salt Lake City, UT, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7129-8137","authenticated-orcid":false,"given":"Peter N","family":"Schlegel","sequence":"additional","affiliation":[{"name":"Department of Urology, Weill Cornell Medicine , New York, NY, USA"}]},{"given":"Jo\u00e3o","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Departamento de Gen\u00e9tica Humana, Instituto Nacional de Sa\u00fade Dr. Ricardo Jorge , Lisboa, Portugal"},{"name":"Centre for Toxicogenomics and Human Health\u2014ToxOmics, Nova Medical School , Lisbon, Portugal"}]},{"given":"Filipa","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Servi\u00e7o de Gen\u00e9tica, Departamento de Patologia, Faculdade de Medicina da Universidade do Porto , Porto, Portugal"},{"name":"i3S\u2014Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto , Porto, Portugal"}]},{"given":"Daniel","family":"Moreno-Mendoza","sequence":"additional","affiliation":[{"name":"Andrology Department, Fundaci\u00f3 Puigvert, Universitat Aut\u00f2noma de Barcelona, Instituto de Investigaciones Biom\u00e9dicas Sant Pau (IIB-Sant Pau) , Barcelona, Spain"},{"name":"Department of Urology, Hospital Francisco Grande Covi\u00e1n , Arriondas, Asturias, Spain"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1832-0307","authenticated-orcid":false,"given":"Kristian","family":"Almstrup","sequence":"additional","affiliation":[{"name":"Department of Growth and Reproduction, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen, Denmark"},{"name":"International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen, Denmark"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5482-0141","authenticated-orcid":false,"given":"Michael L","family":"Eisenberg","sequence":"additional","affiliation":[{"name":"Department of Urology, Stanford University School of Medicine , Stanford, CA, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6966-9114","authenticated-orcid":false,"given":"Keith A","family":"Jarvi","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, Mount Sinai Hospital, University of Toronto , Toronto, ON, Canada"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7298-4940","authenticated-orcid":false,"given":"Moira K","family":"O\u2019Bryan","sequence":"additional","affiliation":[{"name":"School of BioSciences and Bio21 Institute, Faculty of Science, The University of Melbourne , Parkville, Australia"}]},{"given":"Alexandra M","family":"Lopes","sequence":"additional","affiliation":[{"name":"i3S\u2014Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto , Porto, Portugal"},{"name":"IPATIMUP\u2014Instituto de Patologia e Imunologia Molecular da Universidade do Porto , Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3828-8970","authenticated-orcid":false,"given":"Donald F","family":"Conrad","sequence":"additional","affiliation":[{"name":"Division of Genetics, Oregon National Primate Research Center, Oregon Health & Science University , Beaverton, OR, USA"}]},{"name":"GEMINI Consortium","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3828-8970","authenticated-orcid":false,"given":"Donald F","family":"Conrad","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1948-2495","authenticated-orcid":false,"given":"Liina","family":"Nagirnaja","sequence":"additional","affiliation":[]},{"given":"Kenneth I","family":"Aston","sequence":"additional","affiliation":[]},{"given":"Douglas T","family":"Carrell","sequence":"additional","affiliation":[]},{"given":"James M","family":"Hotaling","sequence":"additional","affiliation":[]},{"given":"Timothy G","family":"Jenkins","sequence":"additional","affiliation":[]},{"given":"Rob","family":"McLachlan","sequence":"additional","affiliation":[]},{"given":"Moira K","family":"O\u2019Bryan","sequence":"additional","affiliation":[]},{"given":"Peter N","family":"Schlegel","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5482-0141","authenticated-orcid":false,"given":"Michael L","family":"Eisenberg","sequence":"additional","affiliation":[]},{"given":"Jay I","family":"Sandlow","sequence":"additional","affiliation":[]},{"given":"Emily S","family":"Jungheim","sequence":"additional","affiliation":[]},{"given":"Kenan R","family":"Omurtag","sequence":"additional","affiliation":[]},{"given":"Alexandra M","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Seixas","sequence":"additional","affiliation":[]},{"given":"Filipa","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Barros","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8519-243X","authenticated-orcid":false,"given":"Maris","family":"Laan","sequence":"additional","affiliation":[]},{"given":"Margus","family":"Punab","sequence":"additional","affiliation":[]},{"given":"Ewa","family":"Rajpert-De Meyts","sequence":"additional","affiliation":[]},{"given":"Niels","family":"J\u00f8rgensen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1832-0307","authenticated-orcid":false,"given":"Kristian","family":"Almstrup","sequence":"additional","affiliation":[]},{"given":"Csilla G","family":"Krausz","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6966-9114","authenticated-orcid":false,"given":"Keith A","family":"Jarvi","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9601-6311","authenticated-orcid":false,"given":"Margus","family":"Punab","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu , Tartu, Estonia"},{"name":"Andrology Center, Tartu University Hospital , Tartu, Estonia"},{"name":"Institute of Clinical Medicine, University of Tartu , Tartu, Estonia"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8519-243X","authenticated-orcid":false,"given":"Maris","family":"Laan","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu , Tartu, Estonia"}]}],"member":"286","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"2022110309492405000_deac100-B1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/humu.22725","article-title":"Functional classification of BRCA2 DNA variants by splicing assays in a large minigene with 9 exons","volume":"36","author":"Acedo","year":"2015","journal-title":"Hum Mutat"},{"key":"2022110309492405000_deac100-B2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(20)32667-2","article-title":"Male infertility","volume":"397","author":"Agarwal","year":"2021","journal-title":"Lancet"},{"key":"2022110309492405000_deac100-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2006.043257","article-title":"Clinical and molecular features associated with biallelic mutations in FANCD1\/BRCA2","volume":"44","author":"Alter","year":"2007","journal-title":"J Med Genet"},{"key":"2022110309492405000_deac100-B4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s10038-021-00936-8","article-title":"Secondary findings in 622 Turkish clinical exome sequencing data","volume":"66","author":"Arslan Ate\u015f","year":"2021","journal-title":"J Hum Genet"},{"key":"2022110309492405000_deac100-B5","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/s41436-020-0876-4","article-title":"Clinical outcomes of a genomic screening program for actionable genetic conditions","volume":"22","author":"Buchanan","year":"2020","journal-title":"Genet Med"},{"key":"2022110309492405000_deac100-B6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jmedgenet-2019-106672","article-title":"Homozygous hypomorphic BRCA2 variant in primary ovarian insufficiency without cancer or Fanconi anaemia trait","volume":"58","author":"Caburet","year":"2021","journal-title":"J Med Genet"},{"key":"2022110309492405000_deac100-B7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40246-018-0174-2","article-title":"Secondary findings in 421 whole exome-sequenced Chinese children","volume":"12","author":"Chen","year":"2018","journal-title":"Hum Genomics"},{"key":"2022110309492405000_deac100-B8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00439-013-1331-2","article-title":"Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease","volume":"132","author":"Cooper","year":"2013","journal-title":"Hum Genet"},{"key":"2022110309492405000_deac100-B9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/JU.0000000000000137","article-title":"Bringing prostate cancer germline genetics into clinical practice","volume":"202","author":"Das","year":"2019","journal-title":"J Urol"},{"key":"2022110309492405000_deac100-B10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4111\/icu.2020.61.4.355","article-title":"Clinical correlation among male infertility and overall male health: a systematic review of the literature","volume":"61","author":"Del Giudice","year":"2020","journal-title":"Investig Clin Urol"},{"key":"2022110309492405000_deac100-B11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.urology.2020.07.087","article-title":"Increased mortality among men diagnosed with impaired fertility: analysis of US claims data","volume":"147","author":"Del Giudice","year":"2021","journal-title":"Urology"},{"key":"2022110309492405000_deac100-B12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2005.06.002","article-title":"EAU guidelines on male infertility","volume":"48","author":"Dohle","year":"2005","journal-title":"Eur Urol"},{"key":"2022110309492405000_deac100-B13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","article-title":"Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database","volume":"22","author":"Dominguez-Valentin","year":"2020","journal-title":"Genet Med"},{"key":"2022110309492405000_deac100-B14","doi-asserted-by":"crossref","first-page":"9873954","DOI":"10.1155\/2020\/9873954","article-title":"Cancer surveillance in healthy carriers of germline pathogenic variants in BRCA1\/2: a review of secondary prevention guidelines","volume":"2020","author":"Dullens","year":"2020","journal-title":"J Oncol"},{"key":"2022110309492405000_deac100-B15","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/humu.24278","article-title":"Actionable genomic variants in 6045 participants from the Qatar Genome Program","volume":"42","author":"Elfatih","year":"2021","journal-title":"Hum Mutat"},{"key":"2022110309492405000_deac100-B16","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41436-020-0810-9","article-title":"Frequency of genomic secondary findings among 21,915 eMERGE network participants","volume":"22","author":"Gordon","year":"2020","journal-title":"Genet Med"},{"key":"2022110309492405000_deac100-B17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.eururo.2020.09.005","article-title":"Is infertility a predictor of prostate cancer?","volume":"79","author":"Gul","year":"2021","journal-title":"Eur Urol"},{"key":"2022110309492405000_deac100-B18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41431-018-0284-2","article-title":"1 in 38 individuals at risk of a dominant medically actionable disease","volume":"27","author":"Haer-Wigman","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"2022110309492405000_deac100-B50","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41436-018-0308-x","article-title":"Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study","volume":"21","author":"Hart","year":"2019","journal-title":"Genet Med"},{"key":"2022110309492405000_deac100-B19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/humupd\/dmab030","article-title":"A systematic review of the validated monogenic causes of human male infertility: 2020 update and a discussion of emerging gene\u2013disease relationships","volume":"28","author":"Houston","year":"2021","journal-title":"Hum Reprod Update"},{"key":"2022110309492405000_deac100-B20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.1073834","article-title":"Biallelic inactivation of BRCA2 in Fanconi anemia","volume":"297","author":"Howlett","year":"2002","journal-title":"Science"},{"key":"2022110309492405000_deac100-B21","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1242\/dev.01421","article-title":"Mice expressing a dominant-negative Ret mutation phenocopy human Hirschsprung disease and delineate a direct role of Ret in spermatogenesis","volume":"131","author":"Jain","year":"2004","journal-title":"Development"},{"key":"2022110309492405000_deac100-B22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/gim.2016.190","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics","volume":"19","author":"Kalia","year":"2017","journal-title":"Genet Med"},{"key":"2022110309492405000_deac100-B23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00439-020-02112-y","article-title":"Monogenic causes of non-obstructive azoospermia: challenges, established knowledge, limitations and perspectives","volume":"140","author":"Kasak","year":"2021","journal-title":"Hum Genet"},{"key":"2022110309492405000_deac100-B24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajmg.c.31887","article-title":"Leveraging population-based exome screening to impact clinical care: the evolution of variant assessment in the Geisinger MyCode research project","volume":"187","author":"Kelly","year":"2021","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"2022110309492405000_deac100-B51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13073-018-0607-5","article-title":"Prevalence of pathogenic\/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls","volume":"10","author":"Kim","year":"2018","journal-title":"Genome Med"},{"key":"2022110309492405000_deac100-B25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldab025","article-title":"Translational aspects of novel findings in genetics of male infertility-status quo 2021","volume":"140","author":"Laan","year":"2021","journal-title":"Br Med Bull"},{"key":"2022110309492405000_deac100-B26","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2022110309492405000_deac100-B27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4939-7737-6_7","article-title":"Mouse Genome Informatics (MGI) is the international resource for information on the laboratory mouse","volume":"1757","author":"Law","year":"2018","journal-title":"Methods Mol Biol"},{"key":"2022110309492405000_deac100-B28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.10141014","article-title":"Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1","volume":"10","author":"Lehnhardt","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022110309492405000_deac100-B29","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2022110309492405000_deac100-B30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","article-title":"InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines","volume":"100","author":"Li","year":"2017","journal-title":"Am J Hum Genet"},{"key":"2022110309492405000_deac100-B31","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1210\/jc.2017-00765","article-title":"Ovarian aging in women with BRCA germline mutations","volume":"102","author":"Lin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2022110309492405000_deac100-B32","doi-asserted-by":"crossref","first-page":"634536","DOI":"10.3389\/fcell.2021.634536","article-title":"Genes regulating spermatogenesis and sperm function associated with rare disorders","volume":"9","author":"Linn","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2022110309492405000_deac100-B33","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/j.fertnstert.2006.08.029","article-title":"Report on optimal evaluation of the infertile male","volume":"86","author":"Male Infertility Best Practice Policy Committee of the American Urological Association; Practice Committee of the American Society for Reproductive Medicine","year":"2006","journal-title":"Fertil Steril"},{"key":"2022110309492405000_deac100-B34","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"2022110309492405000_deac100-B35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ajmg.a.32627","article-title":"Ovarian failure and dilated cardiomyopathy due to a novel lamin mutation","volume":"149A","author":"McPherson","year":"2009","journal-title":"Am J Med Genet A"},{"key":"2022110309492405000_deac100-B36","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41436-021-01172-3","article-title":"ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet Med"},{"key":"2022110309492405000_deac100-B37","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1096\/fj.12-215566","article-title":"Differential DNA methylation patterns between high and low responders to a weight loss intervention in overweight or obese adolescents: the EVASYON study","volume":"27","author":"Moleres","year":"2013","journal-title":"FASEB J"},{"key":"2022110309492405000_deac100-B38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.fertnstert.2017.10.028","article-title":"The genetic intersection of male infertility and cancer","volume":"109","author":"Nagirnaja","year":"2018","journal-title":"Fertil Steril"},{"key":"2022110309492405000_deac100-B39","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa2028973","article-title":"Variant PNLDC1, defective piRNA processing, and azoospermia","volume":"385","author":"Nagirnaja","year":"2021","journal-title":"N Engl J Med"},{"key":"2022110309492405000_deac100-B40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.113.206359","article-title":"Hepatocyte nuclear factor 1 regulates the expression of the organic cation transporter 1 via binding to an evolutionary conserved region in intron 1 of the OCT1 gene","volume":"347","author":"O'Brien","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"2022110309492405000_deac100-B41","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1210\/jc.2004-0365","article-title":"A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failure","volume":"89","author":"Orgiana","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2022110309492405000_deac100-B42","first-page":"18","article-title":"Causes of male infertility: a 9-year prospective monocentre study on 1737 patients with reduced total sperm counts","volume":"32","author":"Punab","year":"2017","journal-title":"Hum Reprod"},{"key":"2022110309492405000_deac100-B43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2022110309492405000_deac100-B44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ajhg.2018.07.009","article-title":"A model for genome-first care: returning secondary genomic findings to participants and their healthcare providers in a large research cohort","volume":"103","author":"Schwartz","year":"2018","journal-title":"Am J Hum Genet"},{"key":"2022110309492405000_deac100-B45","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41431-019-0384-7","article-title":"Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests","volume":"27","author":"Thauvin-Robinet","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"2022110309492405000_deac100-B46","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41586-020-2853-0","article-title":"Exome sequencing and characterization of 49,960 individuals in the UK Biobank","volume":"586","author":"Van Hout","year":"2020","journal-title":"Nature"},{"key":"2022110309492405000_deac100-B47","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/humrep\/dev139","article-title":"How successful is TESE-ICSI in couples with non-obstructive azoospermia?","volume":"30","author":"Vloeberghs","year":"2015","journal-title":"Hum Reprod"},{"key":"2022110309492405000_deac100-B48","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"2022110309492405000_deac100-B49","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/humu.23631","article-title":"Evidence-based assessments of clinical actionability in the context of secondary findings: updates from ClinGen\u2019s Actionability Working Group","volume":"39","author":"Webber","year":"2018","journal-title":"Hum Mutat"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/7\/1652\/46775494\/deac100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/7\/1652\/46775494\/deac100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T09:53:18Z","timestamp":1667469198000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/37\/7\/1652\/6583093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,5,10]]},"published-print":{"date-parts":[[2022,6,30]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deac100","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,5,10]]}}}